Value-Added Generic Drug R&D for Cancer, Rheumatology and Dialysis

The company’s policy is to focus on 3 patient categories—cancer, rheumatology and dialysis—and advance the research and development of value-added generic drugs.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2018 →Still being written about.

Directionhelps1 helps · 0 hurts · 0 flat

Loading